We are a Clinical Research Center dedicated to conduct Phase II to IV studies for the national and international industry; we also provide Institutional Review Boards services (Ethics committee and scientific committee), external monitoring services in Phase I to IV, bioequivalence and pharmacokinetics studies, bioequivalence and pharmacokinetics protocol design and training in GCP and local regulations for principal investigators and clinical staff. Our main goal is to provide the best services in the shortest possible time.